Friday, April 27, 2007

RE: FDA CAM Guidline misinformation

----------------- Bulletin Message -----------------
From: Pharmaceuticals KILL People & Animals!
Date: Apr 26, 2007 2:47 PM

The American Association for Health Freedom is pleased to announce a small victory.

The FDA has moved the deadline from April 30, 2007 to May 29, 2007 for public comments to the FDA document 2006D-0480 - Draft Guidance for Industry on Complementary and Alternative Medicine Products and Their Regulation by the Food and Drug Administration. [Visit our website for more information.]

This extension provides us time to execute the most effective strategy, which is to prepare and deliver a reasoned, specific and technically accurate response that covers the law and case history that delineates the FDA’s role, power and authority in these areas.

We have been talking with many members of Congress about the FDA CAM Regulation Guidance and they’re listening. Pressure has been exerted on the FDA from organized groups in the community and from Congress. Unfortunately writing directly to the unelected bureaucrats at the FDA has little impact, even if a million citizens write. Writing to your elected officials, as our earlier alert suggested, has had an impact and we’ve sent thousands of letters to the Hill.

We love the fact that the community is so passionate and wants to be involved. Unfortunately we have seen a lot misinformation traveling the Internet about the “dangers” of the FDA CAM Regulation Guidance. The sky is NOT falling. Whether the deadline is April 30th, May 29th, July 31st or beyond, this guidance document alone does not change the laws and regulations of: functional foods, dietary supplements, medical devices and therapies, religious practices, or practitioners.

We are very concerned that the FDA is over-reaching in the CAM guidance. With the new extension date of May 29, 2007, we now have the time to properly respond to the guidance and provide you, Congress, and the FDA with the specifics of what those problems are and how the guidance should be changed.

Our strategy is built on 15 YEARS of experience advocating health freedom and working with our legal and public policy experts (who are leaders in their fields). Our plan is based on a strategic, credible, and logical review of the document. Our mission is to provide the community with reliable, accurate information and not to raise panic. As one of our board members is fond of saying “we don’t work to be ‘busy’ but work to be ‘effective’.”

For perspective, John Weeks of the Integrator Blog has a very good article where he interviews many members of the health freedom community as well as the FDA. I highly recommend you read this article for more information.

Our general counsel, Mr. Michael Ruggio, is preparing our strategy and comments to the FDA which we believe is the strongest course of action that AAHF can take. Our lobbyist Dr. William Duncan continues to execute our public policy work with Congress, FDA, the Centers for Disease Control, and other government agencies. Our plan is to continually educate our members and others who are interested in our work and at the same time, reassure everyone through direct, first-hand information about what is happening on Capital Hill.

We remain committed to this and other health freedom issues that directly impact the right of the consumer to choose and the practitioner to practice. In terms of the FDA CAM Regulation Guidance, we will proceed with our legal strategy, which includes educating Congress. Quoting John Weeks in the article referenced above, “Vigilance remains critical.”

Please feel free to post and forward this message. Thank you.

Brenna Hill
Executive Director
American Association for Health Freedom
4620 Lee Highway, Suite 210
Arlington, VA 22207
Fax: 703.294.6380


Post a Comment

Subscribe to Post Comments [Atom]

<< Home